Potentiated suppression of Dickkopf-1 in breast cancer by combined administration of the mevalonate pathway inhibitors zoledronic acid and statins. [electronic resource]
Producer: 20160906Description: 623-31 p. digitalISSN:- 1573-7217
- Animals
- Antineoplastic Combined Chemotherapy Protocols -- pharmacology
- Atorvastatin -- administration & dosage
- Breast Neoplasms -- drug therapy
- Cell Line, Tumor -- drug effects
- Diphosphonates -- administration & dosage
- Dose-Response Relationship, Drug
- Female
- Gene Expression Regulation, Neoplastic -- drug effects
- Humans
- Imidazoles -- administration & dosage
- Intercellular Signaling Peptides and Proteins -- genetics
- Mevalonic Acid -- antagonists & inhibitors
- Mice, Nude
- Osteoblasts -- drug effects
- Rosuvastatin Calcium -- administration & dosage
- Simvastatin -- administration & dosage
- Xenograft Model Antitumor Assays
- Zoledronic Acid
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.